牛痘候选疫苗免疫剂量的测定:初步结果

K. Zhugunissov, N. Sarsenkulova, Sh. T. Tabys, D. I. Muzarap, M. Kenzhebaeva, K. B. Barakabaev, D. B. Aidarbekova, A. B. Alieva, S. S. Kilibaev, M. A. Mambetaliev
{"title":"牛痘候选疫苗免疫剂量的测定:初步结果","authors":"K. Zhugunissov, N. Sarsenkulova, Sh. T. Tabys, D. I. Muzarap, M. Kenzhebaeva, K. B. Barakabaev, D. B. Aidarbekova, A. B. Alieva, S. S. Kilibaev, M. A. Mambetaliev","doi":"10.51452/kazatuvc.2023.1(001).1426","DOIUrl":null,"url":null,"abstract":"Determining the effective immunizing dose of a vaccine is one of the important pillars of a vaccination strategy. In this regard, this article presents the results of studies to determine the effective immunizing dose of a candidate cowpox vaccine prepared from the BIEMG-51 strain of the vaccinia virus. At determining a immunizing dose of the vaccine, it was found that in all animals vaccinated at doses of 103 TCID50, 104 TCID50, 105 TCID50, antibodies were not detected in the serum neutralization test (SNT). However, these vaccinated calves at the indicated doses were resistant to the challenge, while the unvaccinated group responded to the challenge and fell ill with the characteristic clinical signs of cowpox. The obtained primary results give grounds for improving the technology of vaccine preparation and in-depth study of the factors of cellular immunity of vaccinated animals in case of poxvirus infections.","PeriodicalId":251258,"journal":{"name":"HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY : Veterinary sciences","volume":"293 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"DETERMINATION OF IMMUNIZING DOSES OF THE COWPOX VACCINE CANDIDATE: PRELIMINARY RESULTS\",\"authors\":\"K. Zhugunissov, N. Sarsenkulova, Sh. T. Tabys, D. I. Muzarap, M. Kenzhebaeva, K. B. Barakabaev, D. B. Aidarbekova, A. B. Alieva, S. S. Kilibaev, M. A. Mambetaliev\",\"doi\":\"10.51452/kazatuvc.2023.1(001).1426\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Determining the effective immunizing dose of a vaccine is one of the important pillars of a vaccination strategy. In this regard, this article presents the results of studies to determine the effective immunizing dose of a candidate cowpox vaccine prepared from the BIEMG-51 strain of the vaccinia virus. At determining a immunizing dose of the vaccine, it was found that in all animals vaccinated at doses of 103 TCID50, 104 TCID50, 105 TCID50, antibodies were not detected in the serum neutralization test (SNT). However, these vaccinated calves at the indicated doses were resistant to the challenge, while the unvaccinated group responded to the challenge and fell ill with the characteristic clinical signs of cowpox. The obtained primary results give grounds for improving the technology of vaccine preparation and in-depth study of the factors of cellular immunity of vaccinated animals in case of poxvirus infections.\",\"PeriodicalId\":251258,\"journal\":{\"name\":\"HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY : Veterinary sciences\",\"volume\":\"293 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY : Veterinary sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.51452/kazatuvc.2023.1(001).1426\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY : Veterinary sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51452/kazatuvc.2023.1(001).1426","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

确定疫苗的有效免疫剂量是疫苗接种战略的重要支柱之一。在这方面,本文介绍了用牛痘病毒BIEMG-51株制备牛痘候选疫苗的有效免疫剂量的研究结果。在确定疫苗的免疫剂量时,发现在接种103 TCID50、104 TCID50和105 TCID50剂量的所有动物中,血清中和试验(SNT)未检测到抗体。然而,这些接种了指定剂量疫苗的小牛对攻击有抵抗力,而未接种疫苗的小牛对攻击有反应,并出现牛痘的典型临床症状。获得的初步结果为改进疫苗制备技术和深入研究接种动物在痘病毒感染时的细胞免疫因素提供了依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
DETERMINATION OF IMMUNIZING DOSES OF THE COWPOX VACCINE CANDIDATE: PRELIMINARY RESULTS
Determining the effective immunizing dose of a vaccine is one of the important pillars of a vaccination strategy. In this regard, this article presents the results of studies to determine the effective immunizing dose of a candidate cowpox vaccine prepared from the BIEMG-51 strain of the vaccinia virus. At determining a immunizing dose of the vaccine, it was found that in all animals vaccinated at doses of 103 TCID50, 104 TCID50, 105 TCID50, antibodies were not detected in the serum neutralization test (SNT). However, these vaccinated calves at the indicated doses were resistant to the challenge, while the unvaccinated group responded to the challenge and fell ill with the characteristic clinical signs of cowpox. The obtained primary results give grounds for improving the technology of vaccine preparation and in-depth study of the factors of cellular immunity of vaccinated animals in case of poxvirus infections.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信